Asia-Pacific lab automation market is projected to register a substantial CAGR of 6.3% in the forecast period 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
Market Segmentation:
By Product Type (Equipment, Software & Informatics, Analyser), Automation Type (Modular Automation, Total Lab Automation), Application (Drug Discovery, Clinical Diagnostics, Bio Analysis, Analytical Chemistry, Protein Engineering, Proteomic Solutions, Lyophilisation, System Biology, Others), End Users (Biotechnology & Pharmaceuticals, Hospitals, Research Institutions, Academics, Private Labs), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific)
Some of the major factors contributing to the growth of the market:
- Increase in R&D expenditure by pharmaceutical and biopharmaceutical companies
- Increasing geriatric population
- Work flow optimization through lab automation
Market Players:
Some of the major players operating in the Asia-Pacific lab automation market are:
- F. Hoffmann-La Roche Ltd
- Siemens
- Abbott
- Agilent Technologies, Inc.
- Danaher
- BD
- PerkinElmer Inc.
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Brooks Automation, Inc.
- Hamilton Company
- Hudson Robotics
- LabWare
- Thermo Fisher Scientific Inc.